
Regeneron Pharmaceuticals: Securities Lawsuit Filed – Gross Law Firm Encourages Investors to Discuss Potential Claims Before March 10, 2025
Important Notice for Regeneron Pharmaceuticals, Inc. (REGN) Shareholders: The Gross Law Firm announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of shareholders of Regeneron Pharmaceuticals, Inc. (REGN) who purchased shares during the period between February 1, 2023, and August…